[{"@timestamp": "2022-01-22T02:10:06.698918Z", "project": {"build": {}, "deployment": {}, "publications": [], "summary": {"description": true}, "website": {"access_time": 739, "bioschemas": false, "copyright": false, "https": true, "last_check": "2022-01-22T02:10:06.626655Z", "license": false, "operational": 200, "ssl": true, "last_month_access": {"average_access_time": 742, "downtime_days": 0, "uptime_days": 30}, "half_year_stat": [{"days": 1, "serie": [1], "status": 503}, {"days": 182, "serie": [51, 131], "status": 200}], "ssl_err": null}}, "@id": "https://openebench.bsc.es/monitor/metrics/tcga-lgg", "@nmsp": null, "@type": "metrics", "@license": "https://creativecommons.org/licenses/by/4.0/"}, {"@timestamp": "2022-01-22T06:08:39.255367Z", "project": {"build": {}, "deployment": {}, "publications": [{"entries": [{"cit_count": 1, "citations": [{"count": 1, "year": "2020"}], "doi": "10.7717/peerj.7414", "pmcid": "PMC6752186", "pmid": "31576231", "ref_count": 21, "refs": [{"count": 1, "year": "1997"}, {"count": 1, "year": "2003"}, {"count": 1, "year": "2004"}, {"count": 1, "year": "2008"}, {"count": 2, "year": "2009"}, {"count": 1, "year": "2010"}, {"count": 1, "year": "2011"}, {"count": 2, "year": "2012"}, {"count": 1, "year": "2014"}, {"count": 2, "year": "2015"}, {"count": 4, "year": "2016"}, {"count": 1, "year": "2017"}, {"count": 3, "year": "2018"}], "title": "Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma.", "year": 2019}]}], "summary": {"description": true}, "website": {"access_time": 739, "bioschemas": false, "copyright": false, "https": true, "last_month_access": {"average_access_time": 742}, "license": false, "operational": 200, "ssl": null, "ssl_err": null, "half_year_stat": [{"days": 79, "serie": [79], "status": 200}]}}, "@id": "https://openebench.bsc.es/monitor/metrics/biotools:tcga-lgg/undefined/portal.gdc.cancer.gov", "@nmsp": "biotools", "@type": "metrics", "@license": "https://creativecommons.org/licenses/by/4.0/"}]